ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1624

Lupus Risk Alleles With High Ethnic Variability Worldwide Are Associated With Renal Disease In Hispanic Patients

Belinda Waltman1, Kimberly E. Taylor2, Joanne Nititham3 and Lindsey A. Criswell3, 1Department of Medicine, University of California, San Francisco, San Francisco, CA, 2Department of Medicine, University of California, San Francisco, Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, San Francisco, CA, 3Department of Medicine, University of California, San Francisco, Rosalind Russell Medical Research Center for Arthritis, San Francisco, CA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Lupus, Outcome measures, polymorphism and race/ethnicity

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus-Human Etiology and Pathogenesis: Genetics and Genomics

Session Type: Abstract Submissions (ACR)

Background/Purpose: Systemic lupus erythematosus (SLE) disproportionately affects minority patients. Non-European ancestry is associated with more severe disease, and conversely, European ancestry is associated with a lower risk of developing renal disease in SLE. Large genetic studies have identified 58 single nucleotide polymorphisms (SNPs) that influence risk of SLE. Separately, the Human Genome Diversity Project (HGDP) has characterized the allele frequency of 650,000 SNPs in 938 people from 53 different populations worldwide. We hypothesized that SLE SNPs with the greatest allele frequency differences across populations compared to Europeans could identify risk alleles that are associated with severe disease manifestations.

Methods: We analyzed the frequency distribution of the 58 SLE SNPs across populations in the HGDP database grouped into 6 geographic regions; 50 SNPs or proxies had available data. For each SNP, we determined the maximum absolute difference (max diff) in mean frequency between each region and Europe. SNPs were selected whose max diff was greater than 4 standard deviations of the distribution of intra-European frequencies. We tested these SNPs in our multiethnic cohort of 1588 SLE patients for severe disease outcomes (renal disease by ACR renal criterion, severe renal disease including severe forms of lupus nephritis on biopsy or end-stage renal disease, and production of double-stranded DNA antibodies) stratified by ethnicity: Caucasian, African American, Hispanic, and Asians. Logistic regression was performed for these 3 outcomes, adjusting for disease duration and gender.

Results: The max diff approach identified 19 SNPs; 13 had been genotyped in our SLE collection. Analysis identified a strong association between renal disease and Hispanic ethnicity: the number of these 13 risk alleles cumulatively increased the risk of renal disease among Hispanic patients (OR=1.2 per allele, p=0.006). Three of the 13 SNPs were individually associated (p ≤ 0.05) with renal disease or severe renal disease. The strongest single allele associations were rs2205960/TNFSF4 (OR=2.2, p=0.0014 for renal disease), rs2736340/BLK (OR 2.1, p=0.006 for severe renal disease and OR 1.6, p=0.05 for renal disease) and rs9888739/ITGAM (OR 1.8, p=0.04 for renal disease). In HGDP data, the Central/South American region was the first or second greatest max diff compared to Europeans for these alleles. 

Conclusion: Using worldwide genetic ancestry data, we identified SLE risk SNPs with high allele frequency variability across populations, postulating that these variants might influence severe disease phenotypes. Indeed, in a multiethnic SLE cohort, these 13 SNPs cumulatively increased the risk of renal disease in Hispanics, and 3 of these 13 alleles were individually associated with renal disease outcomes. This approach may be useful for identifying genetic variants that influence disease severity in SLE.


Disclosure:

B. Waltman,
None;

K. E. Taylor,
None;

J. Nititham,
None;

L. A. Criswell,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lupus-risk-alleles-with-high-ethnic-variability-worldwide-are-associated-with-renal-disease-in-hispanic-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology